BRPI0409980A - uso de derivados de ácido fenoxiacético para tratar bexiga hiperativa - Google Patents

uso de derivados de ácido fenoxiacético para tratar bexiga hiperativa

Info

Publication number
BRPI0409980A
BRPI0409980A BRPI0409980-0A BRPI0409980A BRPI0409980A BR PI0409980 A BRPI0409980 A BR PI0409980A BR PI0409980 A BRPI0409980 A BR PI0409980A BR PI0409980 A BRPI0409980 A BR PI0409980A
Authority
BR
Brazil
Prior art keywords
acid derivatives
overactive bladder
phenoxyacetic acid
treat
treat overactive
Prior art date
Application number
BRPI0409980-0A
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0409980(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BRPI0409980A publication Critical patent/BRPI0409980A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"USO DE DERIVADOS DE áCIDO FENOXIACéTICO PARA TRATAR BEXIGA HIPERATIVA". A presente invenção se refere a um campo novo de indicação para derivados de ácido fenoxiacético com descrito no Pedido de Patente Europeu EP 1095932. Foi constatado agora que os compostos descritos nesta são adequados para a preparação de um medicamento para tratar bexiga hiperativa (bexiga superativa). Conseqüentemente, por meio destas substâncias ativas, um método é fornecido para tratar esta síndrome urológica.
BRPI0409980-0A 2003-05-05 2004-03-24 uso de derivados de ácido fenoxiacético para tratar bexiga hiperativa BRPI0409980A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
PCT/JP2004/004048 WO2004098586A1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
BRPI0409980A true BRPI0409980A (pt) 2006-05-09

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409980-0A BRPI0409980A (pt) 2003-05-05 2004-03-24 uso de derivados de ácido fenoxiacético para tratar bexiga hiperativa

Country Status (26)

Country Link
US (1) US20040229947A1 (pt)
EP (1) EP1620085B1 (pt)
JP (1) JP4602969B2 (pt)
KR (1) KR101052804B1 (pt)
AR (1) AR044169A1 (pt)
AT (1) ATE401878T1 (pt)
AU (1) AU2004236596B2 (pt)
BR (1) BRPI0409980A (pt)
CA (1) CA2524023C (pt)
CL (1) CL2004000952A1 (pt)
CY (1) CY1108425T1 (pt)
DE (1) DE602004015272D1 (pt)
DK (1) DK1620085T3 (pt)
ES (1) ES2309513T3 (pt)
IL (1) IL171713A (pt)
MX (1) MXPA05011862A (pt)
MY (1) MY141756A (pt)
NZ (1) NZ543347A (pt)
PE (1) PE20050524A1 (pt)
PL (1) PL1620085T3 (pt)
PT (1) PT1620085E (pt)
RU (1) RU2342133C2 (pt)
SI (1) SI1620085T1 (pt)
TW (1) TWI351279B (pt)
UY (1) UY28306A1 (pt)
WO (1) WO2004098586A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
US8003694B2 (en) * 2005-04-26 2011-08-23 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60041110D1 (de) * 1999-11-01 2009-01-29 Sumitomo Chemical Co 6-Hydroxy-5,6-dihydrouracile als Herbizide
HUP0401694A3 (en) * 2001-09-13 2008-03-28 Kissei Pharmaceutical Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use

Also Published As

Publication number Publication date
PE20050524A1 (es) 2005-07-07
KR20060009886A (ko) 2006-02-01
AU2004236596B2 (en) 2010-03-11
MY141756A (en) 2010-06-30
CY1108425T1 (el) 2014-04-09
AU2004236596A1 (en) 2004-11-18
DK1620085T3 (da) 2008-11-24
DE602004015272D1 (de) 2008-09-04
TWI351279B (en) 2011-11-01
PT1620085E (pt) 2008-08-07
EP1620085B1 (en) 2008-07-23
WO2004098586A1 (en) 2004-11-18
RU2342133C2 (ru) 2008-12-27
SI1620085T1 (sl) 2008-12-31
EP1620085A1 (en) 2006-02-01
PL1620085T3 (pl) 2009-01-30
IL171713A (en) 2011-12-29
CL2004000952A1 (es) 2005-03-04
CA2524023A1 (en) 2004-11-18
TW200509902A (en) 2005-03-16
CA2524023C (en) 2011-11-22
JP4602969B2 (ja) 2010-12-22
AR044169A1 (es) 2005-08-24
NZ543347A (en) 2008-05-30
RU2005137701A (ru) 2006-06-10
US20040229947A1 (en) 2004-11-18
UY28306A1 (es) 2004-12-31
JP2006525318A (ja) 2006-11-09
ATE401878T1 (de) 2008-08-15
MXPA05011862A (es) 2006-02-17
ES2309513T3 (es) 2008-12-16
KR101052804B1 (ko) 2011-07-29

Similar Documents

Publication Publication Date Title
BRPI0409227C1 (pt) composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)
WO2009066152A3 (en) Haloallylamine inhibitors of ssao/vap-1 and uses therefor
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BR0008979A (pt) Composto quìmico, uso de um composto, método de tratamento, processo de preparação de um composto, composição farmacêutica e método de fabricação da mesma
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
BR0315580A (pt) Derivados de metileno uréia
UY27740A1 (es) Nuevos compuestos
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
NO20082496L (no) Pyrazinderivater
CL2007001784A1 (es) Compuestos derivados de benzoxazol de formula la, su composicion farmaceutica, metodo para medir in vivo depositos de amoloide empleando dicha composicion, y uso del compuesto la para preparar un medicamento, y compuesto de formula ib, y su uso como precursor en la preparacion de un compuesto marcado.
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
WO2004100865A3 (en) New benzimidazole derivatives
BRPI0413742B8 (pt) composto antioxidante quimicamente estável, composição farmacêutica, método de redução do estresse oxidativo em uma célula in vitro e métodos de preparo e de síntese do referido composto antioxidante
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
BRPI0518898A2 (pt) composto, processo para sua preparaÇço, composiÇço farmacÊutica, mÉtodo para tratamento e uso do composto
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
DE602004015406D1 (de) Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen
BRPI0606606A2 (pt) composições estáveis contendo prostaglandina
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
ATE411276T1 (de) Kristalle eines hydroxynorephedrinderivats
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.